logo
logo

Symbiomics secures Series A funding of undisclosed amount, led by Corteva, to enhance microbial discovery and genome-editing technologies.

Jul 01, 2025•15 days ago

Round Type

series a

FlorianopolisFarmingBiotechnology

Investors

The Yield Lab LatamMov InvestimentosCazangaAra CapitalCorteva

Description

Symbiomics announced the closure of its Series A round on June 25, led by Corteva’s Catalyst programme with participation from Ara Capital, Cazanga, MOV Investimentos, and The Yield Lab Latam. The funding will help advance the discovery of novel microbes and develop genome-editing technologies. Symbiomics aims to expand its infrastructure and research team with the investment. Corteva will leverage Symbiomics’ genomics discovery platform to identify novel microbial strains for new products.

Company Information

Company

Symbiomics

Location

Florianopolis, Santa Catarina, Brazil

About

Symbiomics is a Brazilian biologicals start-up focused on the discovery of novel microbes and the development of genome-editing technologies for agricultural applications. The company aims to address global agricultural challenges by leveraging its proprietary genomics discovery platform. It targets the rapidly growing market for biologicals as alternatives to synthetic inputs. Symbiomics collaborates with Corteva and other investors to enhance its research and market entry strategies.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Related People